Evaluation of results of the prostigmine-morphine test with quantitative hepatobiliary scintigraphy

a new method for the diagnosis of sphincter of Oddi dyskinesia

L. Madácsy, B. Velösy, J. Lonovics, L. Csernay

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Attempts have long been made to use the prostigmine-morphine provocation test for the selection of postcholecystectomy patients suffering from sphincter of Oddi (SO) dyskinesia. Since the whole procedure is based upon the evaluation of subjective complaints, this test has frequently been criticized. To improve the diagnostic value of this method, we have visualized SO spasms during prostigmine-morphine provocation by means of quantitative hepatobiliary scintigraphy (QHBS). Twenty-two cholecystectomized patients with typical postprandial biliary pain were included in this study. In the first series of studies, QHBS with technetium-99m 2,6-diethylphenylcarbamoylmethyl-diacetic acid was performed in each patient 2 days before prostigmine-morphine provocation. The time to peak activity (Tmax) and the half-time of excretion (T1/2) over the liver parenchyma (LP), hepatic hilum (HH) and common bile duct (CBD), and the duodenum appearance time (DAT), were determined and served as control values. In the second series of experiments, sphincter spasms were evoked by prostigmine-morphine administration and visualized by means of QHBS. The same parameters were evaluated and serum levels of aspartate aminotransferase (AST) were determined simultaneously at regular intervals. In 12 patients who responded to prostigmine-morphine provocation with typical biliary pain and a significant AST elevation (Nardi positive group) the hepatobiliary scintigram demonstrated a marked biliary obstruction. Tmax and T1/2 over the LP, HH and CBD were significantly increased, while DAT was significantly longer relative to the corresponding data obtained without provocation. Four of the remaining ten patients indicated atypical abdominal pain during prostigmine-morphine provocation, but the AST level remained unchanged in all ten (Nardi negative group). In this group, QHBS revealed a slower, but free transpapillary flow of the tracer: although T1/2 over the LP, HH and CBD appeared to be significantly higher than without provocation, Tmax did not change and an obstructive pattern was not detected on the hepatobiliary scintigram. When QHBS parameters determined during prostigmine-morphine provocation were compared for the Nardi positive and Nardi negative groups, with the exception of Tmax over the LP they were significantly different. QHBS combined with the prostigmine-morphine provocation test proved to be a useful non-invasive method for the detection of pathological sphincter spasms in patients with SO dyskinesia. Application of this method is therefore strongly recommended in the diagnosis of SO dyskinesia.

Original languageEnglish
Pages (from-to)227-232
Number of pages6
JournalEuropean Journal Of Nuclear Medicine
Volume22
Issue number3
DOIs
Publication statusPublished - Mar 1995

Fingerprint

Sphincter of Oddi Dysfunction
Neostigmine
Radionuclide Imaging
Morphine
Liver
Common Bile Duct
Spasm
Aspartate Aminotransferases
Duodenum
Sphincter of Oddi
Pain
Technetium
Abdominal Pain
Patient Selection

Keywords

  • Prostigmine-morphine test
  • Quantitative hepatobiliary scintigraphy
  • Sphincter of Oddi dyskinesia

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

@article{0ecdc6d196a842e8a6de04d4ba19c479,
title = "Evaluation of results of the prostigmine-morphine test with quantitative hepatobiliary scintigraphy: a new method for the diagnosis of sphincter of Oddi dyskinesia",
abstract = "Attempts have long been made to use the prostigmine-morphine provocation test for the selection of postcholecystectomy patients suffering from sphincter of Oddi (SO) dyskinesia. Since the whole procedure is based upon the evaluation of subjective complaints, this test has frequently been criticized. To improve the diagnostic value of this method, we have visualized SO spasms during prostigmine-morphine provocation by means of quantitative hepatobiliary scintigraphy (QHBS). Twenty-two cholecystectomized patients with typical postprandial biliary pain were included in this study. In the first series of studies, QHBS with technetium-99m 2,6-diethylphenylcarbamoylmethyl-diacetic acid was performed in each patient 2 days before prostigmine-morphine provocation. The time to peak activity (Tmax) and the half-time of excretion (T1/2) over the liver parenchyma (LP), hepatic hilum (HH) and common bile duct (CBD), and the duodenum appearance time (DAT), were determined and served as control values. In the second series of experiments, sphincter spasms were evoked by prostigmine-morphine administration and visualized by means of QHBS. The same parameters were evaluated and serum levels of aspartate aminotransferase (AST) were determined simultaneously at regular intervals. In 12 patients who responded to prostigmine-morphine provocation with typical biliary pain and a significant AST elevation (Nardi positive group) the hepatobiliary scintigram demonstrated a marked biliary obstruction. Tmax and T1/2 over the LP, HH and CBD were significantly increased, while DAT was significantly longer relative to the corresponding data obtained without provocation. Four of the remaining ten patients indicated atypical abdominal pain during prostigmine-morphine provocation, but the AST level remained unchanged in all ten (Nardi negative group). In this group, QHBS revealed a slower, but free transpapillary flow of the tracer: although T1/2 over the LP, HH and CBD appeared to be significantly higher than without provocation, Tmax did not change and an obstructive pattern was not detected on the hepatobiliary scintigram. When QHBS parameters determined during prostigmine-morphine provocation were compared for the Nardi positive and Nardi negative groups, with the exception of Tmax over the LP they were significantly different. QHBS combined with the prostigmine-morphine provocation test proved to be a useful non-invasive method for the detection of pathological sphincter spasms in patients with SO dyskinesia. Application of this method is therefore strongly recommended in the diagnosis of SO dyskinesia.",
keywords = "Prostigmine-morphine test, Quantitative hepatobiliary scintigraphy, Sphincter of Oddi dyskinesia",
author = "L. Mad{\'a}csy and B. Vel{\"o}sy and J. Lonovics and L. Csernay",
year = "1995",
month = "3",
doi = "10.1007/BF01081517",
language = "English",
volume = "22",
pages = "227--232",
journal = "European Journal of Pediatrics",
issn = "0340-6199",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Evaluation of results of the prostigmine-morphine test with quantitative hepatobiliary scintigraphy

T2 - a new method for the diagnosis of sphincter of Oddi dyskinesia

AU - Madácsy, L.

AU - Velösy, B.

AU - Lonovics, J.

AU - Csernay, L.

PY - 1995/3

Y1 - 1995/3

N2 - Attempts have long been made to use the prostigmine-morphine provocation test for the selection of postcholecystectomy patients suffering from sphincter of Oddi (SO) dyskinesia. Since the whole procedure is based upon the evaluation of subjective complaints, this test has frequently been criticized. To improve the diagnostic value of this method, we have visualized SO spasms during prostigmine-morphine provocation by means of quantitative hepatobiliary scintigraphy (QHBS). Twenty-two cholecystectomized patients with typical postprandial biliary pain were included in this study. In the first series of studies, QHBS with technetium-99m 2,6-diethylphenylcarbamoylmethyl-diacetic acid was performed in each patient 2 days before prostigmine-morphine provocation. The time to peak activity (Tmax) and the half-time of excretion (T1/2) over the liver parenchyma (LP), hepatic hilum (HH) and common bile duct (CBD), and the duodenum appearance time (DAT), were determined and served as control values. In the second series of experiments, sphincter spasms were evoked by prostigmine-morphine administration and visualized by means of QHBS. The same parameters were evaluated and serum levels of aspartate aminotransferase (AST) were determined simultaneously at regular intervals. In 12 patients who responded to prostigmine-morphine provocation with typical biliary pain and a significant AST elevation (Nardi positive group) the hepatobiliary scintigram demonstrated a marked biliary obstruction. Tmax and T1/2 over the LP, HH and CBD were significantly increased, while DAT was significantly longer relative to the corresponding data obtained without provocation. Four of the remaining ten patients indicated atypical abdominal pain during prostigmine-morphine provocation, but the AST level remained unchanged in all ten (Nardi negative group). In this group, QHBS revealed a slower, but free transpapillary flow of the tracer: although T1/2 over the LP, HH and CBD appeared to be significantly higher than without provocation, Tmax did not change and an obstructive pattern was not detected on the hepatobiliary scintigram. When QHBS parameters determined during prostigmine-morphine provocation were compared for the Nardi positive and Nardi negative groups, with the exception of Tmax over the LP they were significantly different. QHBS combined with the prostigmine-morphine provocation test proved to be a useful non-invasive method for the detection of pathological sphincter spasms in patients with SO dyskinesia. Application of this method is therefore strongly recommended in the diagnosis of SO dyskinesia.

AB - Attempts have long been made to use the prostigmine-morphine provocation test for the selection of postcholecystectomy patients suffering from sphincter of Oddi (SO) dyskinesia. Since the whole procedure is based upon the evaluation of subjective complaints, this test has frequently been criticized. To improve the diagnostic value of this method, we have visualized SO spasms during prostigmine-morphine provocation by means of quantitative hepatobiliary scintigraphy (QHBS). Twenty-two cholecystectomized patients with typical postprandial biliary pain were included in this study. In the first series of studies, QHBS with technetium-99m 2,6-diethylphenylcarbamoylmethyl-diacetic acid was performed in each patient 2 days before prostigmine-morphine provocation. The time to peak activity (Tmax) and the half-time of excretion (T1/2) over the liver parenchyma (LP), hepatic hilum (HH) and common bile duct (CBD), and the duodenum appearance time (DAT), were determined and served as control values. In the second series of experiments, sphincter spasms were evoked by prostigmine-morphine administration and visualized by means of QHBS. The same parameters were evaluated and serum levels of aspartate aminotransferase (AST) were determined simultaneously at regular intervals. In 12 patients who responded to prostigmine-morphine provocation with typical biliary pain and a significant AST elevation (Nardi positive group) the hepatobiliary scintigram demonstrated a marked biliary obstruction. Tmax and T1/2 over the LP, HH and CBD were significantly increased, while DAT was significantly longer relative to the corresponding data obtained without provocation. Four of the remaining ten patients indicated atypical abdominal pain during prostigmine-morphine provocation, but the AST level remained unchanged in all ten (Nardi negative group). In this group, QHBS revealed a slower, but free transpapillary flow of the tracer: although T1/2 over the LP, HH and CBD appeared to be significantly higher than without provocation, Tmax did not change and an obstructive pattern was not detected on the hepatobiliary scintigram. When QHBS parameters determined during prostigmine-morphine provocation were compared for the Nardi positive and Nardi negative groups, with the exception of Tmax over the LP they were significantly different. QHBS combined with the prostigmine-morphine provocation test proved to be a useful non-invasive method for the detection of pathological sphincter spasms in patients with SO dyskinesia. Application of this method is therefore strongly recommended in the diagnosis of SO dyskinesia.

KW - Prostigmine-morphine test

KW - Quantitative hepatobiliary scintigraphy

KW - Sphincter of Oddi dyskinesia

UR - http://www.scopus.com/inward/record.url?scp=0028933148&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028933148&partnerID=8YFLogxK

U2 - 10.1007/BF01081517

DO - 10.1007/BF01081517

M3 - Article

VL - 22

SP - 227

EP - 232

JO - European Journal of Pediatrics

JF - European Journal of Pediatrics

SN - 0340-6199

IS - 3

ER -